Codexis is a leading enzyme engineering and biotechnology enterprise that develops high-performance enzymes and specialized proteins using its proprietary CodeEvolver technology platform. The company specializes in sustainable manufacturing solutions for pharmaceutical development, enabling cleaner, more efficient biocatalysis chemical synthesis processes. Additionally, Codexis focuses on developing advanced nucleic acid synthesis solutions through its ECO Synthesis platform, helping partner companies accelerate drug discovery, lower production costs, and reduce environmental footprints across industrial and medical supply chains.